HIF1A and neoplasm: Furthermore, markers such as HIF1 (a proangiogenic factor) and PDGFRA (a kinase contributing to angiogeneisis and frequently targeted by angiogenesis inhibitor drugs), while having increased expression in the angiogenic tumor subtype, were identified as targeted for repression in the non-angiogenic subnetwork.